FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,963,369 | -15.0% | 261,434 | -0.0% | 0.00% | – |
| Q2 2023 | $2,308,913 | +13.6% | 261,485 | -20.1% | 0.00% | – |
| Q1 2021 | $2,032,000 | -20.0% | 327,151 | -4.1% | 0.00% | – |
| Q4 2020 | $2,541,000 | +27.7% | 341,051 | +3.9% | 0.00% | – |
| Q3 2020 | $1,990,000 | -15.5% | 328,306 | +16.5% | 0.00% | – |
| Q2 2020 | $2,354,000 | +189.9% | 281,868 | +68.4% | 0.00% | – |
| Q1 2019 | $812,000 | -21.4% | 167,372 | +3.4% | 0.00% | – |
| Q4 2018 | $1,033,000 | -19.2% | 161,918 | +4.0% | 0.00% | – |
| Q3 2018 | $1,278,000 | -17.5% | 155,725 | +5.0% | 0.00% | – |
| Q2 2018 | $1,549,000 | – | 148,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |